Now Enrolling Dogs with Bladder Cancer
Principal Investigator
Description
NC State University College of Veterinary Medicine is enrolling in a clinical trial to investigate if a probiotic can improve cancer care and outcomes in dogs with bladder cancer. This is a placebo-controlled study, not all dogs will receive the probiotic, but all dogs will receive
chemotherapy (vinblastine/piroxicam).
Testing Requirements
Dogs who are strongly suspected of having urothelial carcinoma by the referring veterinarian. All cases will be biopsy confirmed following initial screening.
Enrollment Start
01/19/2023
Enrollment Finish
12/31/2024
Eligibility
• Cancer must be primarily located within the bladder.
• Female dogs must weigh at least 6kg.
• Male dogs must weigh at least 10kg.
• Complete blood count and serum chemistry without clinically significant abnormalities, as determined by a veterinarian.
Exclusions
• No history of chronic GI or skin problems
• No recent use of antibiotics, H2 blockers, or proton pump inhibitors (3 weeks)
• Not on any diet/treat containing probiotics within the past 3 weeks
• Not on a raw diet within the past 3 weeks
• No history of chemotherapy or radiation
Think your dog may be eligible? Click the link below.
Flyer
Contact
Ashley Fuhrer
cvmclinicalstudies@ncsu.edu
919-515-3634
- Categories: